人工智能在真实世界乳腺筛查中的应用
本文讨论乳腺X线筛查中AI算法的应用现状,指出既往回顾性研究在大型数据集上显示AI表现可与人类阅片者相当,但测试集性质、金标准计算方式、阳性判定定义及统计方法均影响结果,且回顾性研究未能预测真实世界中放射科医生联合机器的表现,因此需在引入AI前开展前瞻性研究。
要点
- 回顾性研究显示的AI性能不能预测真实筛查中放射科医生联合机器的表现。
- 测试集性质、金标准、阳性定义和统计方法均影响AI性能评估结果。
- 将AI引入真实乳腺筛查前需开展前瞻性研究验证。
核心结论
- 回顾性研究尚未能预测放射科医生联合AI在真实乳腺筛查中的表现,需前瞻性研究验证后方可引入临床。
研究设计与样本
- 本文为论述性文章,未报告具体研究类型、样本量、中心数、设备或参考标准。
临床应用与阅片要点
- 阅片和报告中应认识到回顾性AI性能数据不能直接外推至真实筛查场景。
局限性
- 原文指出回顾性研究历史上未能预测放射科医生联合机器的真实表现,需前瞻性研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Breast cancer screening with mammography reduces mortality in the women who attend by detecting high risk cancer early. It is far from perfect with variations in both sensitivity for the detection of cancer and very wide variations in specificity, leading to unnecessary recalls and biopsies. Over the last 12 months several papers have reported on AI algorithms that perform as well as human readers on large well curated population data sets. The nature of the test sets, the way the gold standard has been calculated, the definition of a positive call, and the statistics used all influence the results. Historically retrospective studies have not predicted the real-life performance of radiologist plus machine. So, it is important to perform prospective studies before introducing Artificial intelligence into real world breast screening.
引用
- Wallis MG. Artificial intelligence for the real world of breast screening. Eur J Radiol. 2021. PMID: 34598013. doi:10.1016/j.ejrad.2021.109661
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。